06-25 Induct AS: Publication of company presentation PU
06-19 Induct Plans Up to NOK20 Million Capital Raise Via Underwritten Rights Issue MT
06-15 Induct : Invitation to company presentation PU
05-29 Induct : Annual Report 2025 – Events after the balance sheet date PU
05-13 Induct AS Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-16 Induct : Finansiell kalender PU
02-12 Induct AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-13 Induct AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
20/10/25 Induct notifies regulator of possible market abuse violations RE
22/09/25 Induct : Meldepliktig handel for primærinnsider – Styremedlem og største aksjonær øker eierandelen PU
15/08/25 Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
14/08/25 Induct Q2 Ebitda Nok 3.3 Mln RE
14/08/25 Induct : Interim Report Q2 2025 PU
18/07/25 Induct CFO steps down RE
07/07/25 Induct Raises NOK6 Million in Private Placement to Reduce Debt MT
07/07/25 Induct completes private placement RE
27/05/25 Induct, Norne Securities Enter Into Market Making Agreement RE
23/05/25 Induct: Astrazeneca Starts Commercial Discussions Earlier Than Planned RE
23/05/25 Induct AS: AstraZeneca Initiates Commercial Discussions Earlier Than Planned AQ
24/04/25 Management Software Developer Induct Raises NOK14.5 Million from Share Sale MT
10/04/25 Induct AS Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
10/04/25 Induct Q1 EBITDA Rises To NOK 3.0 Mln RE
05/03/25 Induct Says Hittabidrag Signs Its First Municipal Agreement RE
13/02/25 Induct AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
14/11/24 Induct AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
No results match your criteria